384 related articles for article (PubMed ID: 24957811)
1. Time course of asymmetric dimethylarginine and symmetric dimethylarginine levels after successful renal transplantation.
Claes KJ; Bammens B; Kuypers DR; Meijers B; Naesens M; Sprangers B; Vanrenterghem Y; Lerut E; de Loor H; Evenepoel P
Nephrol Dial Transplant; 2014 Oct; 29(10):1965-72. PubMed ID: 24957811
[TBL] [Abstract][Full Text] [Related]
2. Symmetric dimethylarginine (SDMA) outperforms asymmetric dimethylarginine (ADMA) and other methylarginines as predictor of renal and cardiovascular outcome in non-dialysis chronic kidney disease.
Emrich IE; Zawada AM; Martens-Lobenhoffer J; Fliser D; Wagenpfeil S; Heine GH; Bode-Böger SM
Clin Res Cardiol; 2018 Mar; 107(3):201-213. PubMed ID: 29101459
[TBL] [Abstract][Full Text] [Related]
3. Symmetric and asymmetric dimethylarginine as risk markers of cardiovascular disease, all-cause mortality and deterioration in kidney function in persons with type 2 diabetes and microalbuminuria.
Zobel EH; von Scholten BJ; Reinhard H; Persson F; Teerlink T; Hansen TW; Parving HH; Jacobsen PK; Rossing P
Cardiovasc Diabetol; 2017 Jul; 16(1):88. PubMed ID: 28697799
[TBL] [Abstract][Full Text] [Related]
4. Asymmetrical (ADMA) and symmetrical dimethylarginine (SDMA) as potential risk factors for cardiovascular and renal outcome in chronic kidney disease - possible candidates for paradoxical epidemiology?
Busch M; Fleck C; Wolf G; Stein G
Amino Acids; 2006 May; 30(3):225-32. PubMed ID: 16680555
[TBL] [Abstract][Full Text] [Related]
5. Methylated arginine derivatives in children and adolescents with chronic kidney disease.
Brooks ER; Langman CB; Wang S; Price HE; Hodges AL; Darling L; Yang AZ; Smith FA
Pediatr Nephrol; 2009 Jan; 24(1):129-34. PubMed ID: 18830716
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic value of plasma asymmetric and symmetric dimethylarginine levels in liver transplant recipients.
Wnuk Z; Kokot F; Kunsdorf-Wnuk A
Pol Arch Med Wewn; 2012; 122(7-8):367-73. PubMed ID: 22688059
[TBL] [Abstract][Full Text] [Related]
7. Increased symmetrical dimethylarginine in ischemic acute kidney injury as a causative factor of renal L-arginine deficiency.
Betz B; Möller-Ehrlich K; Kress T; Kniepert J; Schwedhelm E; Böger RH; Wanner C; Sauvant C; Schneider R
Transl Res; 2013 Aug; 162(2):67-76. PubMed ID: 23707198
[TBL] [Abstract][Full Text] [Related]
8. Serum reference intervals of homoarginine, ADMA, and SDMA in the study of health in Pomerania.
Atzler D; Schwedhelm E; Nauck M; Ittermann T; Böger RH; Friedrich N
Clin Chem Lab Med; 2014 Dec; 52(12):1835-42. PubMed ID: 24945429
[TBL] [Abstract][Full Text] [Related]
9. Arginine, dimethylated arginine and homoarginine in relation to cardiovascular risk in patients with moderate chronic kidney disease.
Hov GG; Aasarød KI; Sagen E; Åsberg A
Clin Biochem; 2015 Jul; 48(10-11):646-51. PubMed ID: 25828044
[TBL] [Abstract][Full Text] [Related]
10. Serum concentrations of asymmetric (ADMA) and symmetric (SDMA) dimethylarginine in renal failure patients.
Fleck C; Janz A; Schweitzer F; Karge E; Schwertfeger M; Stein G
Kidney Int Suppl; 2001 Feb; 78():S14-8. PubMed ID: 11168976
[TBL] [Abstract][Full Text] [Related]
11. HPLC determination of plasma dimethylarginines: method validation and preliminary clinical application.
Ivanova M; Artusi C; Boffa GM; Zaninotto M; Plebani M
Clin Chim Acta; 2010 Nov; 411(21-22):1632-6. PubMed ID: 20542018
[TBL] [Abstract][Full Text] [Related]
12. Asymmetric and Symmetric Dimethylarginine Predict Outcomes in Patients With Atrial Fibrillation: An ARISTOTLE Substudy.
Horowitz JD; De Caterina R; Heresztyn T; Alexander JH; Andersson U; Lopes RD; Steg PG; Hylek EM; Mohan P; Hanna M; Jansky P; Granger CB; Wallentin L;
J Am Coll Cardiol; 2018 Aug; 72(7):721-733. PubMed ID: 30092948
[TBL] [Abstract][Full Text] [Related]
13. Serum concentrations of asymmetric (ADMA) and symmetric (SDMA) dimethylarginine in patients with chronic kidney diseases.
Fleck C; Schweitzer F; Karge E; Busch M; Stein G
Clin Chim Acta; 2003 Oct; 336(1-2):1-12. PubMed ID: 14500028
[TBL] [Abstract][Full Text] [Related]
14. Circulating levels of dimethylarginines, chronic kidney disease and long-term clinical outcome in non-ST-elevation myocardial infarction.
Cavalca V; Veglia F; Squellerio I; De Metrio M; Rubino M; Porro B; Moltrasio M; Tremoli E; Marenzi G
PLoS One; 2012; 7(11):e48499. PubMed ID: 23185262
[TBL] [Abstract][Full Text] [Related]
15. Serum L-arginine and dimethylarginine levels in migraine patients with brain white matter lesions.
Erdélyi-Bótor S; Komáromy H; Kamson DO; Kovács N; Perlaki G; Orsi G; Molnár T; Illes Z; Nagy L; Kéki S; Deli G; Bosnyák E; Trauninger A; Pfund Z
Cephalalgia; 2017 May; 37(6):571-580. PubMed ID: 27206959
[TBL] [Abstract][Full Text] [Related]
16. Measurement of arginine derivatives in pediatric patients with chronic kidney disease using high-performance liquid chromatography-tandem mass spectrometry.
Wang S; Vicente FB; Miller A; Brooks ER; Price HE; Smith FA
Clin Chem Lab Med; 2007; 45(10):1305-12. PubMed ID: 17663630
[TBL] [Abstract][Full Text] [Related]
17. Symmetric Dimethylarginine Assay Validation, Stability, and Evaluation as a Marker for the Early Detection of Chronic Kidney Disease in Dogs.
Nabity MB; Lees GE; Boggess MM; Yerramilli M; Obare E; Yerramilli M; Rakitin A; Aguiar J; Relford R
J Vet Intern Med; 2015; 29(4):1036-44. PubMed ID: 26079532
[TBL] [Abstract][Full Text] [Related]
18. Asymmetric dimethylarginine is not elevated in exfoliation syndrome but symmetric dimethylarginine is related to exfoliative glaucoma.
Blomster H; Puustjärvi T; Kontkanen M; Valtonen P; Teräsvirta M; Uusitalo H
Graefes Arch Clin Exp Ophthalmol; 2007 Feb; 245(2):204-9. PubMed ID: 17024436
[TBL] [Abstract][Full Text] [Related]
19. Admission levels of asymmetric and symmetric dimethylarginine predict long-term outcome in patients with community-acquired pneumonia.
Vögeli A; Ottiger M; Meier MA; Steuer C; Bernasconi L; Kulkarni P; Huber A; Christ-Crain M; Henzen C; Hoess C; Thomann R; Zimmerli W; Mueller B; Schuetz P
Respir Res; 2017 Jan; 18(1):25. PubMed ID: 28114935
[TBL] [Abstract][Full Text] [Related]
20. Relations between plasma asymmetric dimethylarginine (ADMA) and risk factors for coronary disease.
Wang J; Sim AS; Wang XL; Salonikas C; Naidoo D; Wilcken DE
Atherosclerosis; 2006 Feb; 184(2):383-8. PubMed ID: 15939423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]